Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05704569 Completed - Stroke Clinical Trials

Prediction of Primary Cardiovascular Events Using the Multimarker Approach

Start date: June 1, 2014
Phase:
Study type: Observational

The study of biochemical risk factors for cardiovascular diseases is important not only for analysis, but also for preventive measures, given that changes in the level of biomarkers can be detected before the first clinical manifestations of CVD. Accordingly, patients at high CV risk may have additional motivation to lead a healthy lifestyle. In addition, information on biochemical risk markers can be used to optimize the clinical management of patients.

NCT ID: NCT05703906 Completed - Stroke Clinical Trials

Teleneurorehabilitation for the Continuity of Care Post-stroke: a Multicentric Pilot Study

TELEICTUS
Start date: March 16, 2018
Phase: N/A
Study type: Interventional

The main aim of this longitudinal, pilot study is to evaluate the feasibility of a multi-domain (i.e., motor, language and cognitive domains) telerehabilitation system using the Virtual Reality Rehabilitation System (VRRS, Khymeia) in patients with stroke. Furthermore, data on patients' needs and clinical data will be collected before and after treatment and then analyzed.

NCT ID: NCT05689528 Completed - Clinical trials for Acute Ischemic Stroke

The Screening of Neuroprotective Biomarkers After Acute Ischemic Stroke

Start date: July 1, 2017
Phase:
Study type: Observational

Neuroprotection is expected to be an important therapeutic strategy for acute ischemic stroke(AIS), but almost all neuroprotective drugs proved effective in rodent models have failed after entering clinical trials. This study aims to screen the differentially expressed proteins in peripheral blood of patients with acute ischemic stroke and with further study in the animal model of non-human primate cerebral infarction, we may determine the biomarkers that can evaluate the efficacy of neuroprotective drugs.

NCT ID: NCT05678816 Completed - Stroke Clinical Trials

Effect Of Breather On Pulmonary And Physical Function In Post Stroke Survivors

Start date: September 15, 2022
Phase: N/A
Study type: Interventional

Stroke is the second major cause of death and disability worldwide with over 13 million new cases annually. Egypt, a low-middle-income country, is the most populated nation in the Middle East with a high overall crude prevalence rate of stroke (963/100,000 inhabitants), accounting for 6.4% of all deaths and the incidence of stroke annually is approximately 150,000-210,000. Stroke has a direct impact on health systems, resulting in high costs, and is also considered a global public health problem due to serious disabilities, functional limitations and compromised quality of life (QoL). The Breather a drug-free, evidence-based inspiratory/expiratory respiratory muscle training (RMT) device used by Dysphagia, COPD, CHF, Parkinson's, and neuromuscular disease patients, as well as children 4+ and adults interested in healthy aging.

NCT ID: NCT05668169 Completed - Stroke Clinical Trials

Family-centered Support Program for Caregivers of Stroke Survivors

Start date: August 16, 2021
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the effect of a family-centered support program on the care burden, depressive symptoms, perceived social support, and quality of life of stroke survivor' caregivers and on care recipients' rehabilitation adherence and depressive symptoms.

NCT ID: NCT05666388 Completed - Thrombosis Clinical Trials

Rescue Stenting in the Severe Atherosclerotic Stenosis After the Failure of Intravenous Thrombolysis

RESFIT
Start date: May 1, 2020
Phase: N/A
Study type: Interventional

Intravenous (IV) recombinant tissue plasminogen activator is the standard of care for patients with acute ischemic stroke (AIS) who present to the hospital within 4.5 hours of symptom onset. However, IV thrombolysis, even bridging thrombolysis (combining intravenous thrombolysis and mechanical thrombectomy) has limited efficacy among patients who had occlusive lesions associated with highgrade arterial stenosis requiring revascularization to improve neurological deficits. The investigators evaluated whether rescue stenting results in good outcomes among patients after the failure of intravenous thrombolysis and bridging thrombolysis.

NCT ID: NCT05661396 Completed - Stroke Clinical Trials

Therapeutic Serious Game and Rehabilitation of Stroke Patient

Start date: November 3, 2016
Phase: N/A
Study type: Interventional

The growing field of new technologies offers new perspectives for neurorehabilitation. Serious games are a promising solution in the rehabilitation of cognitive impairments, and they may be useful in the rehabilitation of unilateral spatial neglect. The investigators developed a rehabilitation program for visual exploration training with a serious game and investigated its efficiency. Six patients with unilateral spatial neglect after a right hemispheric stroke were recruited. Three patients assigned to the experimental group received both serious game training and conventional rehabilitation, and three assigned to the control group received only conventional rehabilitation. The investigators compared the two groups after rehabilitation.

NCT ID: NCT05660902 Completed - Stroke Clinical Trials

EFFECT OF EXERCISES IN PATIENTS WITH STROKE

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Aim: This study was conducted as a randomized controlled experimental study to determine the effect of ROM exercises applied to individuals who had a stroke on functional independence and quality of life. Design: This study was conducted as a randomized controlled experimental study Methods: The study was conducted with 80 individuals, 40 of whom were in the intervention group and 40 in the control group, who received inpatient treatment in the neurology service of a regional city hospital, and met the inclusion criteria. Planned ROM exercises were applied to the individuals in the intervention group 3 times a day for 2 weeks, and no application was made to the control group other than routine treatment. Data were collected by the researcher using the Questionnaire Form, Patient Information Form, Functional Independence Scale and Stroke Specific Quality of Life Scale.

NCT ID: NCT05655039 Completed - Stroke Clinical Trials

The Effect of Pre-rehabilitation and Rehabilitation Period on Functional Status in Inpatient Stroke Patients

Start date: September 15, 2022
Phase:
Study type: Observational

Patients who underwent inpatient rehabilitation for the last 5 years were retrospectively scanned. The pre-rehabilitation and rehabilitation periods of the patients were determined. At the beginning and end of rehabilitation, patients were evaluated with the Brunsstrom, Barthel and Stroke Impact Scale. The effect of the specified durations on these scales was investigated.

NCT ID: NCT05637996 Completed - Stroke Clinical Trials

Reliability and Validity of the Selective Control of the Upper Extremity Scale in Stroke Patients

Start date: February 1, 2022
Phase:
Study type: Observational

Selective motor control is defined as the ability to perform the movement in isolation without revealing movement in another joint, without mirror movements, without using a flexor or extensor pattern in the extremities during a desired movement in one joint. Evaluation of selective motor control is important to predict future functional status in adult stroke patients. The Fugl-Meyer Upper Extremity Motor Rating Scale is the basic test in the assessment of motor functions in stroke patients. However, this test is a complicated scale and it takes more than one hour to complete the rating of the patient; Physicians without experience cannot perform the test because it is difficult. This planned study aims to demonstrate the validity and reliability of Selective Control of the Upper Extremity Scale (SCUES) in the evaluation of selective motor control of upper extremity in stroke patients; thus, it aims to present SCUES to medical professionals as a practical clinical tool to be used in stroke.